LEADER 01555nam  2200397Ia 450 
001 9910698854603321
005 20090514150030.0
035   $a(CKB)5470000002397319
035   $a(OCoLC)320964305
035   $a(EXLCZ)995470000002397319
100   $a20090514d2006      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $echaracterization and qualification of cell substrates and other biological starting materials used in the production of viral vaccines for the prevention and treatment of infectious diseases
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2006]
215   $aii, 49 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 14, 2009).
300   $a"September, 2006".
320   $aIncludes bibliographical references (pages 44-46).
517   $aGuidance for industry 
606   $aBiologicals$zUnited States
606   $aViral vaccines$zUnited States
606   $aCommunicable diseases$zUnited States$xPrevention
615  0$aBiologicals
615  0$aViral vaccines
615  0$aCommunicable diseases$xPrevention.
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698854603321
996   $aGuidance for industry$93434577
997   $aUNINA